Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles Tagged With: COVID-19

  • With Domestic Violence Increasing, Family Planning Providers Should Screen for Signs

    Recent research suggests domestic violence may be increasing during the COVID-19 pandemic. Family planning clinics will need creative techniques to screen for signs as many visits continue through telehealth.

  • COVID-19 Can Cause Neurological Symptoms and Strokes in Patients

    One major health problem related to COVID-19 involves neurological symptoms and signs of brain injury. Patients with COVID-19 can experience acute periods of confusion, post-traumatic amnesia, and delirium. Physicians and researchers do not know what will happen to patients with COVID-19 over the long term and whether they will fully regain their prior cognitive status.

  • Case Managers Can Guide Patients with COVID-19 to Rehab Services

    After days, weeks, or even months of hospitalization with COVID-19, patients often need considerable help with their post-discharge recovery. This is especially true for people who need pulmonary, brain injury, or cardiac rehabilitation. Hospital case managers can help patients recover by educating them about various rehabilitation services.

  • Lessons Learned — or Not — from Hydroxychloroquine Mishap

    The research community’s decades of work to build public trust in IRB oversight and the clinical trial process has reached one of its greatest challenges during the COVID-19 pandemic. Misinformation spread through social media and some media outlets, as well as contradictory instructions and information from political and public health officials, have helped create distrust. Through the spring of 2020, misinformation about hydroxychloroquine as a COVID-19 therapeutic proliferated after President Trump spoke about it as a cure.

  • Minority Recruitment for COVID-19 Trials Is Low While Disease Burden Is High

    More than 350,000 people said they were interested in volunteering for a COVID-19 vaccine trial in the United States, and only 10% of those who signed up are Black and Hispanic. Actual trial enrollment among two companies with large COVID-19 vaccine trials in the U.S. includes only one in five volunteers who are Black and Hispanic.

  • COVID-19 Misinformation Affects Everyone in Research Community

    Clinical trial recruitment for COVID-19 studies faces a new challenge: Rampant misinformation. Since COVID-19 was declared a national emergency and pandemic, fake news, false cures, ill-informed posts, and conspiracy theories have dominated the social media space. One of the challenges from an IRB perspective involves informed consent and public trust in the shadows of the misinformation world.

  • Vaccine Trials Should Follow the Four Ethical Principles

    All human research, including COVID-19 vaccine trials, should be guided by the four ethical principles of autonomy, beneficence, nonmaleficence, and justice. When researchers, data safety monitoring boards, or the Food and Drug Administration decide to stop a clinical trial or expedite approval or use of an investigational product, these principles still apply.

  • A COVID-19 Vaccine at ‘Warp Speed’ Raises Myriad Ethical Questions

    The United States is at a challenging and possibly dangerous crossroad as the desire for speedy development of a COVID-19 vaccine might be pushing political concerns ahead of safety, efficacy, and the regulatory process, bioethicists and researchers say.

  • CDC Backs Down on Testing Controversy

    After widespread criticism from the medical community, the Centers for Disease Control and Prevention dropped a controversial recommendation that de-emphasized the importance of testing asymptomatic contacts of COVID-19 cases.

  • COVID-19 Prevention May Equal Flu Prevention

    Masking, physical distancing, and other measures implemented to slow the pandemic appear to be dramatically reducing influenza outbreaks.